A Sardella1, F Bellone1, N Morabito1, S Minisola2, G Basile1, F Corica1, A Catalano3. 1. Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. 2. Department of Internal Medicine and Medical Disciplines, "Sapienza" Rome University, Rome, Italy. 3. Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. catalanoa@unime.it.
Abstract
CONTEXT AND PURPOSE: Hypocalcemia and low parathyroid hormone levels have been commonly suggested as factors able to induce central nervous system disturbances. However, evidences on the occurrence of cognitive impairment are limited or underestimated. The aim of this review is, therefore, to systematically summarize the available evidence concerning the occurrence of cognitive impairment among subjects suffering from idiopathic or secondary hypoparathyroidism. METHODS: A systematic selection of the available literature was performed by searching the online databases PubMed, Scopus and Web of Knowledge. RESULTS: The present systematic review included sixteen case report articles and one cross-sectional controlled study. Case reports were the most representative literature sources and involved ten women and seven men. The presence of cognitive impairment was mostly discussed in association with idiopathic hypoparathyroidism (HPT); five articles described the occurrence of cognitive impairment following postsurgical HPT. The case-controlled study reported a significant presence of peculiar cognitive deficits (e.g. reduced inhibitory control, impairment in visuo-spatial functioning among, and psychomotor retardation) among HPT subjects compared to healthy controls, with serum total calcium and its product with phosphorus as independent predictors of neuropsychological dysfunctions. CONCLUSION: Even though mostly based on single case reports, the presence of neuropsychological dysfunctions in the context of HPT appears to be a consistent core finding.
CONTEXT AND PURPOSE:Hypocalcemia and low parathyroid hormone levels have been commonly suggested as factors able to induce central nervous system disturbances. However, evidences on the occurrence of cognitive impairment are limited or underestimated. The aim of this review is, therefore, to systematically summarize the available evidence concerning the occurrence of cognitive impairment among subjects suffering from idiopathic or secondary hypoparathyroidism. METHODS: A systematic selection of the available literature was performed by searching the online databases PubMed, Scopus and Web of Knowledge. RESULTS: The present systematic review included sixteen case report articles and one cross-sectional controlled study. Case reports were the most representative literature sources and involved ten women and seven men. The presence of cognitive impairment was mostly discussed in association with idiopathic hypoparathyroidism (HPT); five articles described the occurrence of cognitive impairment following postsurgical HPT. The case-controlled study reported a significant presence of peculiar cognitive deficits (e.g. reduced inhibitory control, impairment in visuo-spatial functioning among, and psychomotor retardation) among HPT subjects compared to healthy controls, with serum total calcium and its product with phosphorus as independent predictors of neuropsychological dysfunctions. CONCLUSION: Even though mostly based on single case reports, the presence of neuropsychological dysfunctions in the context of HPT appears to be a consistent core finding.
Authors: Dan Mungas; Laurel Beckett; Danielle Harvey; Sarah Tomaszewski Farias; Bruce Reed; Owen Carmichael; John Olichney; Joshua Miller; Charles DeCarli Journal: Psychol Aging Date: 2010-09
Authors: G Bühler; S Balabanova; S Milowski; J Rosenthal; G Antoniadis; K Mohr; H P Richter Journal: Exp Clin Endocrinol Diabetes Date: 1997 Impact factor: 2.949
Authors: Ilianna Lourida; Jo Thompson-Coon; Chris M Dickens; Maya Soni; Elżbieta Kuźma; Katarina Kos; David J Llewellyn Journal: PLoS One Date: 2015-05-26 Impact factor: 3.240
Authors: Elena V Kovaleva; Anna K Eremkina; Alina R Elfimova; Julia A Krupinova; Ekaterina E Bibik; Irina S Maganeva; Anna M Gorbacheva; Ekaterina A Dobreva; Galina A Melnichenko; Natalia G Mokrysheva Journal: Front Endocrinol (Lausanne) Date: 2022-02-16 Impact factor: 5.555
Authors: F Saponaro; G Alfi; F Cetani; A Matrone; L Mazoni; M Apicella; E Pardi; S Borsari; M Laurino; E Lai; A Gemignani; C Marcocci Journal: J Endocrinol Invest Date: 2022-06-25 Impact factor: 5.467